Relevare Pharmaceuticals Presents Latest Clinical Trial Data On CNSB015 At Third International Congress On Neuropathic . . .

Posted on June 6, 2010 by admin

Relevare Pharmaceuticals Presents Latest Clinical Trial Data On CNSB015 At Third International Congress On Neuropathic …
Relevare Pharmaceuticals Ltd. will present its recent Phase IIa proof-of-concept clinical trial data and extension study results for CNSB015 (flupirtine), its lead repositioned compound, at the Third International Congress on Neuropathic Pain on May 27 – 30 in Athens, Greece. Dr…

Read more on Medical News Today

About admin

I am a pharmacist in ubonratana hospital for ten years.
This entry was posted in Diabetic neuropathy and tagged , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>